On March 15, 2016, diagnostic test manufacturer Alere Inc. disclosed that the DOJ had requested documents related to the company’s sales practices in Africa, Asia, and Latin America, and other matters related to the FCPA. The DOJ’s subpoena sought information about Alere’s dealings with third parties including government officials. The SEC is also investigating the company’s revenue recognition practices in Africa and China, but the company did not disclose whether the two investigations are linked. Alere previously entered into to an agreement to be acquired by Abbott Laboratories, and the company said that it still expects the transaction to be completed by the end of 2016.